FDA Authorizes Lower Disease Risk Claim for Select Philip Morris Zyn Nicotine Pouches

Benzinga_recent_news07-01

The U.S. Food and Drug Administration on Tuesday granted modified risk tobacco product (MRTP) orders to Philip Morris International Inc.’s (NYSE:PM) subsidiary for 20 ZYN nicotine pouch products. The ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2648442455?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=240,format=auto,quality=85/files/images/story/2026/07/01/Motala--Sweden--10-May-2022-Zyn-Snus-Fro.jpg","is_english":true,"pubTime":"2026-07-01 22:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2648442455","market":"hk","top_or_hot":-1,"title":"FDA Authorizes Lower Disease Risk Claim for Select Philip Morris Zyn Nicotine Pouches","media":"Benzinga_recent_news","content":"<div>\n<p>The U.S. Food and Drug Administration on Tuesday granted modified risk tobacco product (MRTP) orders to Philip Morris International Inc.’s (NYSE:PM) subsidiary for 20 ZYN nicotine pouch products.\nThe ...</p>\n\n<a href=\"https://www.benzinga.com/news/fda/26/07/60220645/fda-authorizes-lower-disease-risk-claim-for-select-philip-morris-zyn-nicotine-pouches\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Authorizes Lower Disease Risk Claim for Select Philip Morris Zyn Nicotine Pouches</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Authorizes Lower Disease Risk Claim for Select Philip Morris Zyn Nicotine Pouches\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-01 22:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/fda/26/07/60220645/fda-authorizes-lower-disease-risk-claim-for-select-philip-morris-zyn-nicotine-pouches><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The U.S. Food and Drug Administration on Tuesday granted modified risk tobacco product (MRTP) orders to Philip Morris International Inc.’s (NYSE:PM) subsidiary for 20 ZYN nicotine pouch products.\nThe ...</p>\n\n<a href=\"https://www.benzinga.com/news/fda/26/07/60220645/fda-authorizes-lower-disease-risk-claim-for-select-philip-morris-zyn-nicotine-pouches\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1043141123.HKD","symbol_name":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (HKD) INC 2","start_time":0,"source_url":"https://www.benzinga.com/news/fda/26/07/60220645/fda-authorizes-lower-disease-risk-claim-for-select-philip-morris-zyn-nicotine-pouches","article_id":"2648442455","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=240,format=auto,quality=85/files/images/story/2026/07/01/Motala--Sweden--10-May-2022-Zyn-Snus-Fro.jpg"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/fda/26/07/60220645/fda-authorizes-lower-disease-risk-claim-for-select-philip-morris-zyn-nicotine-pouches","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2648442455","pubTimestamp":1782917940,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"FDA authorizes Philip Morris' unit to market 20 ZYN nicotine pouches with reduced disease risk claims after scientific review.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1043141123.HKD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (HKD) INC 2","LU0690374961.EUR":"FUNDSMITH EQUITY \"R\" (EUR) INC","HK0000914686.HKD":"GFI Global Select Equity Fund Class A (HKD)","LU0314106906.USD":"MANULIFE GF GLOBAL EQUITY \"AA\" (USD) INC","LU0690374615.EUR":"FUNDSMITH EQUITY \"R\" (EUR) ACC","SLCT":"Select Bancorp Inc.","LOHA":"Roundhill HALO ETF","HK0000914660.USD":"GFI Global Select Equity Fund Class A (USD)","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","LU1066051225.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AC\" (USD) ACC","BK4585":"ETF&股票定投概念","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","PM":"菲利普莫里斯","LU0994945656.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) INC 2","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU0265550359.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A2\" (USD) ACC","LU0949170772.SGD":"Blackrock Global Equity Income A6 SGD-H","LU0545562505.USD":"NINETY ONE GSF GLOBAL QUALITY DIVIDEND GROWTH \"A\" (USD) INC","BK4566":"资本集团","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","LU1121112475.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USDHDG) ACC","LU0265550946.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A5\" (USD) INC","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","LU2404859667.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) ACC","LU1116320737.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (USD) INC","LU0661504455.SGD":"Blackrock Global Equity Income A5 SGD-H","LU0426412945.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) ACC","LU0738911758.USD":"Blackrock Global Equity Income A6 USD","LU1066051811.HKD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (HKD) INC","LU0426417589.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) INC","BK4588":"碎股","GB00B4QBRK32.GBP":"FUNDSMITH EQUITY \"R\" (GBP) INC","LU1228905037.USD":"NINETY ONE GSF GLOBAL QUALITY DIVIDEND GROWTH \"A\" (USD) ACC","LU2381873111.SGD":"BGF SYSTEMATIC GLOBAL EQUITY HIGH INCOME \"A6\" (SGDHDG) INC","LABU":"三倍做多标普生物-Direxion","GB00B4LPDJ14.GBP":"FUNDSMITH EQUITY \"R\" (GBP) ACC","LU1043141396.HKD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (HKD) ACC","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","LU2404859741.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) INC","BK4075":"烟草","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","LU1116320901.HKD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (HKD) INC","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU1228905540.USD":"NINETY ONE GSF GLOBAL QUALITY DIVIDEND GROWTH \"A\" (USD) INC 2"},"translate_title":"FDA批准部分菲利普莫里斯Zyn尼古丁袋降低疾病风险的声明","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LABU":1.5,"PM":1,"SLCT":1.5,"LOHA":1.5},"content_text":"The U.S. Food and Drug Administration on Tuesday granted modified risk tobacco product (MRTP) orders to Philip Morris International Inc.’s (NYSE:PM) subsidiary for 20 ZYN nicotine pouch products.\nThe update allows the company to market them with claims that switching completely from cigarettes to the products lowers the risk of several smoking-related diseases.\nThe decision follows an extensive scientific review and applies only to the authorized ZYN products, not to nicotine pouches as a broader category.\nThe modified risk orders cover 10 ZYN varieties—Chill, Cinnamon, Citrus, Coffee, Cool Mint, Menthol, Peppermint, Smooth, Spearmint, and Wintergreen—each available in 3 milligram and 6 milligram nicotine strengths.\nThe agency emphasized that MRTP orders apply only to the specific products reviewed and do not extend to an entire class of tobacco products.\nAs part of the authorization, Swedish Match company must conduct postmarket surveillance and research to assess consumer behavior and understanding of the modified risk information. The orders will expire in five years unless the company receives renewed authorization.\nThe FDA said it may withdraw the orders if continued marketing no longer benefits public health, including if youth uptake rises significantly. The agency reiterated that no tobacco product is safe and that individuals who do not use tobacco should not start.\nTo date, the FDA has authorized 26 nicotine pouch products after determining they meet the statutory public health standard.\n\"FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,\" Philip Morris U.S. CEO Stacey Kennedy told CNBC. \n\"Today’s news ensures these adults have access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer.\"\nPM Stock Price Activity: Philip Morris shares were down 0.90% at $179.27 at the time of publication on Wednesday, according to Benzinga Pro data.\nPhoto by Jeppe Gustafsson via Shutterstock\nTo add Benzinga News as your preferred source on Google, click here.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2648442455","isCrawlerRequest":true}